Admission Date:  [**2192-5-18**]              Discharge Date:   [**2192-5-24**]   Service: CARDIOTHORACIC  Allergies: Iodine Containing Agents Classifier / Heparin Agents  Attending:[**First Name3 (LF) 1283**] Chief Complaint: Patient returned from [**Hospital3 **] after UE ultrasound revealed LUE DVT involving entire subclavian.
PEG in place Ext: Warm no pedal edema, + left arm edema  Discharge VS 98.6  81SR  142/50  18  100% on 40%TM Gen: NAD Neuro: Alert, responsive follows commands CV: RRR, sternum stable wound CDI Pulm: scattered rhonchi w/productive cough Abdm: soft +BS/PEG site CDI Ext: Warm no pedal edema, 1+ LUE edema  Pertinent Results: [**2192-5-17**] 04:48AM   GLUCOSE-187* UREA N-28* CREAT-0.7 SODIUM-145 POTASSIUM-4.4 CHLORIDE-110* TOTAL CO2-27 ANION GAP-12 [**2192-5-17**] 04:48AM   WBC-9.5 RBC-3.68* HGB-10.6* HCT-32.9* MCV-89 MCH-28.7 MCHC-32.2 RDW-15.1 [**2192-5-17**] 04:48AM   PLT COUNT-291 [**2192-5-24**] 08:40AM BLOOD PT-21.1* PTT-41.1* INR(PT)-2.0*  Brief Hospital Course: Admitted to [**Hospital1 18**] [**5-18**] from [**Hospital3 **] for tx of UE DVT in HIT+ patient w/Argatroban and transition to Warfarin.
The patient was also begun on Warfarin and dose was titrated up while maintaining Argatroba infusion until [**5-24**] pt had therapeudic INR and Argatroban infusion was stopped.
Her blood sugars will need to be monitored for additional dose adjustments.
Warfarin 2 mg Tablet Sig: as directed Tablet PO once a day: 5mg [**5-24**] then as directed to maintain target INR 2-2.5.
